Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Autism Spectrum Disorders: early-phase trial registry
1 of 21 indexed Autism Spectrum Disorders trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #797 of 28,707 conditions by registered trial count.
21 US clinical trials · 1 currently recruiting · #797 of 28,707 conditions by registered trial count
Autism Spectrum Disorders: 21 US clinical trials tracked, 1 recruiting.
Autism Spectrum Disorders is the subject of 21 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most active sponsor is Massachusetts General Hospital, running 3 of these trials.
Enrollment posture brief
Registry condition autism-spectrum-disorders
OPEN 1 | RECR 5% | LATE 0 | EARLY 8 | RANK #797 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Recurrent Breast Cancer (5% recruiting · 20 trials)
Autism Spectrum Disorders lists 1 open slots (5% of 21 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Autism Spectrum Disorders on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Autism Spectrum Disorders is recruiting below its size-band peers.
1 of 21 indexed trials (4.8%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Autism Spectrum Disorders trials is spread across many organizations.
Massachusetts General Hospital accounts for 3 of 21 trials (14.3%). 15 distinct sponsors appear on at least one study for this condition label.
-
Most Autism Spectrum Disorders trials plan to enrol fewer than 100 people.
Median target enrolment is 40 among the 21 trials that report a genuine target (sentinel values excluded). 14 of those (66.7%) plan for fewer than 100 participants.
-
Autism Spectrum Disorders research is mostly interventional.
18 interventional and 3 observational studies make up this index (85.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
21 total, page 1 of 1
Water Competency Intervention in Autism
Ohio State University
NCT07076264
Phenotypic and Genetic Factors in Autism Spectrum Disorders
Boston Children's Hospital
NCT00910559
Project AFECT (Autism Family Empowerment Coaching and Training Program)
Stanford University
NCT05910502
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
Forest Laboratories
NCT01592747
Screening and Linkage to Services for Autism
University of Colorado, Denver
NCT02374541
Psychotherapy for Anxiety in Children With Autism Spectrum Disorder
University of South Florida
NCT02028247
Understanding Gastrointestinal Conditions in Children With Autism Spectrum Disorder (ASD)
Massachusetts General Hospital
NCT01675414
Improving Services and Outcomes for Children With Autism Spectrum Disorder (ASD)
Hugo W. Moser Research Institute at Kennedy Krieger
NCT01800539
The Role of Vasopressin in the Social Deficits of Autism
Stanford University
NCT01962870
Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder
Hugo W. Moser Research Institute at Kennedy Krieger
NCT01694667
Pivotal Response Treatment for Children With Autism Spectrum Disorders
Yale University
NCT01908686
Brain Imaging Study of Adults With Autism Spectrum Disorders
National Institute of Mental Health (NIMH)
NCT01093768
Syracuse University Fit Families Program: Autism
Syracuse University
NCT02940899
Autism Spectrum Disorders (ASD) Characterization Study
Massachusetts General Hospital
NCT00801554
Telehealth Coaching for Families of Children With Autism
University of Kansas Medical Center
NCT02928068
Acamprosate in Youth With Fragile X Syndrome
Indiana University
NCT01300923
Probiotics for Quality of Life in Autism Spectrum Disorders
Ohio State University
NCT02903030
Virtual Reality Social Cognition Training for Adults With Autism Spectrum Disorders
Yale University
NCT02139514
University of California, San Diego (UCSD) Suramin Autism Treatment-1 (SAT1) Trial
University of California, San Diego
NCT02508259
Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders
Children's Hospital Medical Center, Cincinnati
NCT02081027
An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders
Massachusetts General Hospital
NCT01931033
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Autism Spectrum Disorders records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Autism Spectrum Disorders trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Autism Spectrum Disorders page
21 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Autism Spectrum Disorders trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Massachusetts General Hospital sponsors the most Autism Spectrum Disorders trials on record, review their full trial history before evaluating a specific study. See Massachusetts General Hospital's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Autism Spectrum Disorders condition card totals 21 registered trials; most-linked intervention Vasopressin; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.